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Inflammatory Response in Skin
Xiaoli Xia1, Zhiheng Li1, Kewei Liu1, Yelin Wu1, Deming Jiang1 and Yuping Lai1Staphylococcus epidermidis (S. epidermidis) plays a critical role in modulating cutaneous inflammatory
responses in skin. Although S. epidermidis has been shown to co-colonize with Propionibacterium acnes
(P. acnes) in acne lesions, it is unclear whether S. epidermidis is involved in the regulation of P. acnes-induced
inflammatory responses. In this study, we demonstrated that S. epidermidis inhibited P. acnes-induced
inflammation in skin. P. acnes induced the expression of interleukin-6 and tumor necrosis factor-a via the
activation of toll-like receptor (TLR) 2 in both keratinocytes and mouse ears. Staphylococcal lipoteichoic acid
activated TLR2 to induce miR-143 in keratinocytes, and miR-143, in turn, directly targeted 30 UTR of TLR2 to
decrease the stability of TLR2 mRNA and then decreased TLR2 protein, thus inhibiting P. acnes-induced
proinflammatory cytokines. The inhibitory effect of miR-143 was further confirmed in vivo as the administration
of miR-143 antagomir into mouse ears abrogated the inhibitory effect of lipoteichoic acid on P. acnes-induced
inflammation in skin. Taken together, these observations demonstrate that staphylococcal lipoteichoic acid
inhibits P. acnes-induced inflammation via the induction of miR-143, and suggest that local modulation of
inflammatory responses by S. epidermidis at the site of acne vulgaris might be a beneficial therapeutic strategy
for management of P. acnes-induced inflammation.
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Inflammation is a fundamental process in the development of
acne lesions. Propionibacterium acnes (P. acnes), a normal
inhabitant of the lipid-rich sebaceous glands in the skin, has
been suggested to be one of major causative agents of this
process. For instance, Propionibacteria are identifiable in
68% of 1-day-old acne lesions and 79% of 3-day-old lesions
by biopsy studies in patients with clinically inflamed acne
vulgaris (Leeming et al., 1988). Moreover, application of
P. acnes to unaffected areas of skin in patients with acne
results in clinical inflammation and pustule development
(Fleming, 1909; Strauss and Kligman, 1960). These findings
thereby demonstrate that there is an association between
P. acnes and clinically inflammatory acne.
Increasing evidence shows that P. acnes activates toll-like
receptor 2 (TLR2) to induce various proinflammatory cyto-
kines such as interleukin (IL)-1a and tumor necrosis factor-a
(TNF-a) in both monocytic cells and keratinocytes (Kim et al.,1Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences,
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article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by2002; Shibata et al., 2009). In addition to TLR2, TLR4 has
been reported to be involved in the induction of inflammatory
cytokines by P. acnes (Jugeau et al., 2005). These cytokines are
considered to be responsible for the further follicular hyper-
keratinization and the inflammatory lesions of acne (Gollnick,
2003; Kurokawa et al., 2009; Zouboulis et al., 2005).
Although the role of P. acnes in the inflammatory responses of
acne lesions is well defined, how to regulate P. acnes-induced
inflammation in the skin is not fully explored.
MicroRNAs (miRNAs) are single-stranded noncoding
RNAs (approximately 20e25 nucleotides) that regulate gene
expression on a posttranscriptional level (Ambros, 2004;
Bartel, 2004). One of key roles of miRNAs is to regulate in-
flammatory responses by acting as positive or negative reg-
ulators (Baltimore et al., 2008; Ceribelli et al., 2012;
O’Connell et al., 2012). For example, miR-155 exerts both
pro- and anti-inflammatory activities in myeloid cells,
depending on the context and the availability of targeting
mRNAs. miR-155 increased cellular inflammatory responses
to lipopolysaccharide by directly repressing Src homology-2
domain-containing inositol 5-phosphatase 1 in macro-
phages (O’Connell et al., 2009) or reduced regulatory T-cell
numbers to ensure robust inflammatory responses by inhib-
iting suppressor of cytokine signaling 1 in lymphoid (Lu et al.,
2009), whereas miR-155 downregulated inflammatory cyto-
kine production by directly controlling the level of TAB2-
TAK1-binding protein 2 in human monocyte-derived
dendritic cells in response to microbial stimuli (Ceppi et al.,
2009). In addition to miR-155, miR-146a was discovered to
directly downregulate TNF receptor-associated factor 6
(TRAF6) and IL-1 receptor-associated kinase 1, two of the
signal transducers in NF-kB pathway, thus dampening orestigative Dermatology. This is an open access
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622terminating an inflammatory response in human monocytic
cells (Taganov et al., 2006). Moreover, miR-143 was shown to
suppress IL-13-induced inflammatory cytokine and mucus
production by targeting and suppressing IL-13 receptor a1
chain gene expression in nasal epithelial cells from patients
with allergic rhinitis (Teng et al., 2015). However, whether
miRNAs are regulated to suppress inflammatory responses
during acne development remains unknown.
Staphylococcus epidermidis (S. epidermidis), a major
constituent of the normal microflora on healthy human skin,
has been shown to co-colonize with P. acnes in acne lesions
(Fitz-Gibbon et al., 2013; Nishijima et al., 2000). Although
S. epidermidis shows a beneficial role in human health by
preventing pathogen colonization (Lai et al., 2010; Li et al.,
2013), little is known about whether S. epidermidis was
involved in the regulation of P. acnes-induced inflammatory
responses. Our recent work has revealed that S. epidermidis
and its byproduct lipoteichoic acid (LTA) suppress TLR3-
dependent inflammation by the induction of a negative regu-
lator TRAF1 after skin injury (Lai et al., 2009). In this study, we
sought to determine whether S. epidermidis might also
modulate P. acnes-induced inflammatory responses by
inducingmiRNAs in keratinocytes.Our findings reveal a potent
role of staphylococcal LTA in inhibiting P. acnes-induced
inflammation in skin, and provide insights into how this skin
resident microbe could act to minimize skin inflammation.
RESULTS
S. epidermidis inhibits P. acnes-induced inflammation in skin
S. epidermidis has been found to co-colonize with P. acnes in
acne lesions (Fitz-Gibbon et al., 2013; Nishijima et al., 2000),
and our previous study has demonstrated that less than 10 kDa
sterile supernatant of S. epidermidis culturemedium (SECM) or
staphylococcal LTA inhibits the release of inflammatory cyto-
kines in keratinocytes and wound inflammation after skin
injury (Lai et al., 2009).We thereby hypothesized that SECMor
LTA from S. epidermidis might be able to regulate P. acnes-
induced inflammatory responses. To test this, SECM or
commercial LTA from Staphylococcus aureus resembling LTA
from S. epidermidiswas intradermally injected intomouse ears
before an infectious challenge at the site with living P. acnes.
Mice treated with SECM or LTA showed decreased cutaneous
erythema and ear swelling that were caused by P. acneswhen
compared with control mice injected with P. acnes (Figure 1a
and b). The decrease in inflammation corresponded with a
decrease in the expression of interleukin-6 (IL-6) and TNF-a
mRNA (Figure 1c and d). To exclude that the inhibition of
P. acnes-induced inflammation by SECMor LTAwas not due to
decreased growth of P. acnes, P. acneswas first incubatedwith
SECM or LTA in vitro. Both SECM and LTA were unable to
inhibit the growth of P. acnes (Figure 1e and f). Consistent with
the in vitro observation, the ex vivo study also showed that
SECMand LTAdid not decrease the bacterial load of P. acnes in
mouse ears (Figure 1g and h). Taken together, these results
demonstrate that S. epidermidis inhibits P. acnes-induced
inflammation not via limiting the growth of P. acnes in skin.
S. epidermidis selectively inhibits P. acnes-induced
inflammatory cytokines in keratinocytes
It has been reported that P. acnes induces inflammatory
responses in peritoneal macrophages (Kim et al., 2002). WeJournal of Investigative Dermatology (2016), Volume 136have also observed that P. acnes significantly induced the
expression of IL-6 and TNF-a mRNA in dose- and time-
dependent manners in macrophages (Figure 2a and b),
whereas SECM or LTA did not inhibit these cytokines in
macrophages (Figure 2c and d). Besides macrophages,
P. acnes induced the expression of IL-6 and TNF-a mRNA in
dose- and time-dependent manners in keratinocytes with the
maximum induction observed at 2.5  107 CFU of P. acnes
treatment for 3 hours (Figure 2e and f), and SECM or LTA
significantly inhibited P. acnes-induced IL-6 and TNF-a in
keratinocytes (Figure 2g and h). These data suggest that SECM
or staphylococcal LTA selectively inhibits P. acnes-induced
inflammation in keratinocytes.
miR-143 is required for LTA to inhibit P. acnes-induced
inflammatory cytokines
To explore the underlying mechanism by which
S. epidermidis inhibits P. acnes-induced inflammation in
keratinocytes, we set out to evaluate whether miRNAs might
be involved in this event. Small interfering RNAs targeting to
Dicer were used. Silencing of Dicer significantly blocked the
inhibitory effect of LTA on P. acnes-induced IL-6 and TNF-a
expression in keratinocytes (Figure 3a), suggesting that LTA
regulates miRNAs to inhibit P. acnes-induced inflammatory
response in keratinocytes.
To further identify the specific miRNAs involved in the
inhibition of P. acnes-induced inflammatory responses, the
expression of several pre-miRNAs was evaluated in kerati-
nocytes after exposure to LTA. LTA significantly induced
the expression of pre-miR-143 and pre-miR-146a, but
not pre-miR-548v and pre-miR579 in keratinocytes
(Figure 3b and Supplementary Figure S1 online). The
increased expression of pre-miR-143 and pre-miR-146a by
LTA was also observed in LTA-treated mouse ears
(Figure 3c). However, LTA did not induce the expression of
pre-miR-143 or slightly induced pre-miR-146a expression
in macrophages (Figure 3d). To evaluate whether miR-143
or miR-146a was involved in LTA inhibition of P. acnes-
induced inflammatory response, pre-miR-143 or pre-miR-
146 was overexpressed or inhibited in primary human
keratinocytes before P. acnes and/or LTA stimulation. The
overexpression of miR-146 and miR-143 significantly
inhibited P. acnes-induced IL-6 and TNF-a expression in
keratinocytes (Figure 3e and f), whereas the inhibition of
miR-143 but not miR-146 abrogated the inhibitory effect of
LTA on P. acnes-induced IL-6 and TNF-a in keratinocytes
(Figure 3g and h). These data demonstrate that LTA inhibits
P. acnes-induced inflammatory response specifically
dependent on miR-143 in keratinocytes.
LTA activates TLR2 to induce miR-143
Having identified the involvement of miR-143 in the regu-
lation of P. acnes-induced inflammatory response by LTA, we
next sought to explore the mechanism by which staphylo-
coccal LTA induces miR-143 in keratinocytes. TLR2 is a
well-known receptor for staphylococcal LTA. To determine
whether LTA activated TLR2 to induce miR-143, we first
analyzed the expression of TLR2 induced by LTA. LTA
significantly induced the expression of TLR2 mRNA in pri-
mary human and murine keratinocytes as well as in mouse
ears (Figure 4aec). Consistent with increased mRNA, LTA
Figure 1. Staphylococcus epidermidis
inhibits Propionibacterium acnes-
induced inflammation in skin.
Wild-type mice were injected
intradermally with 1  107 CFU of
P. acnes and/or 10 mg of SECM (a) or
2.5  107 CFU of P. acnes and/or
10 mg of staphylococcal LTA (b).
Inflammation in ears was
photographed 12 hours after injection,
and then mice were euthanized to
measure ear thickness 24 hours after
injection. (c) Quantification of IL-6
and TNF-a mRNA expression in ears
treated as in (a) or (d) as in (b). The
survival of P. acnes after incubating
with different doses of SECM (e) or
with 10 mg ml1 LTA (f) for 7 days.
(g) The survival of P. acnes in mouse
ears treated as in (a). (h) The survival of
P. acnes in mouse ears treated as in
(b). **P < 0.01 and ***P < 0.001.
P values were determined by one-way
ANOVA. Data are the means  SEM
of n ¼ 6 and representative of three
independent experiments. ANOVA,
analysis of variance; LTA, lipoteichoic
acid; SECM, S. epidermidis culture
medium; SEM, standard error of the
mean; TNF, tumor necrosis factor.
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manner with the maximum induction observed after 2 hours
of stimulation in primary human and murine keratinocytes
(Figure 4d and e) but after 6 hours of stimulation in mouse
ears (Figure 4f). Moreover, LTA induced miR-143 expression
in a time-dependent manner in primary human keratinocytes,
murine keratinocytes, and mouse ears (Figure 4gei). The in-
duction of miR-143 by LTA was TLR2 dependent as LTA lost
its capacity to induce miR-143 expression in Tlr2-deficient
primary murine keratinocytes and in mouse ears compared
with wild-type controls (Figure 4h and i). Altogether, these
data show that LTA activates TLR2 to induce the expression of
miR143 in keratinocytes.
miR-143 mediates LTA inhibition of P. acnes-induced
inflammation by targeting TLR2
It has been reported that miR-143 blocks TLR2 to suppress
the invasion and migration of human colorectal carcinoma
cells (Guo et al., 2013), and TLR2 has been shown to
be involved in P. acnes-induced inflammatory response
in monocytic cells (Kim et al., 2002). We thereby pro-
posed that miR-143 induced by LTA might target TLR2
to inhibit P. acnes-induced inflammation. To test this, the role
of TLR2 in the induction of inflammatory cytokines by
P. acnes in keratinocytes was first confirmed. Heat-
inactivated P. acnes significantly induced the expression
of IL-6 and TNF-a in human and murine keratinocytes,
whereas this induction was significantly inhibited by TLR2
inhibitor oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (OxPAPC) in human keratinocytes or in
Tlr2-deficient murine keratinocytes (Figure 5a and b).
Consistent with our in vitro observation, living P. acnes
lost its capacity to induce the expression of IL-6 and TNF-
a in Tlr2-deficient mice compared with wild-type con-
trols (Figure 5c and d). All these confirm that TLR2 is also
required for P. acnes to induce inflammatory response in
keratinocytes.
Having known that P. acnes activates TLR2 to induce in-
flammatory response, we next sought to determine whether
miR-143 might target 30UTR of TLR2 mRNA to block TLR2
signaling. P. acnes increased both mRNA and protein of TLR2
in primary human keratinocytes, whereas overexpression of
miR143 decreased TLR2 expression (Figure 5e and f). To
further confirm that TLR2 is a direct target of miR-143, firefly
luciferase reporters containing the complete 30UTR of TLR2
or 30UTR of TLR2 with point mutations in miR-143 recogni-
tion site were constructed, respectively. As expected,
cotransfection with miR-143 in Hela cells dramatically
attenuated 30UTR of TLR2-driven luciferase activity, whereas
miR-143 was not able to inhibit the luciferase activity driven
by 30UTR of TLR2 with the mutation in miR-143 recognition
site (Figure 5g). Moreover, LTA significantly inhibited 30UTR
of TLR2-driven luciferase activity and this inhibitory effect
was abolished by treatment with anti-miR-143, an antagonist
for miR-143 (Figure 5h). In addition to miR-143 inhibitor, the
mutation of miR-143 recognition site in 30UTR of TLR2
abrogated the inhibitory effect of LTA on 30UTR of TLR2-





keratinocytes. Quantification of IL-6
and TNF-a expression in macrophage
RAW264.7 stimulated with different
doses of heat-inactivated P. acnes for
24 hours (a) or 1  107 CFU of heat-
inactivated P. acnes for different times
(b). Quantification of IL-6 and TNF-a
expression in macrophage RAW264.7
stimulated with heat-inactivated
1  107 CFU of P. acnes for 12 hours
in the presence or absence of SECM
(36 mg ml1) (c) or LTA (10 mg ml1)
(d). Quantification of IL-6 and TNF-a
expression in primary human
keratinocytes stimulated with different
doses of heat-inactivated P. acnes
for 3 hours (e) or 2.5  107 CFU of
heat-inactivated P. acnes for different
times (f). Quantification of IL-6 and
TNF-a expression in primary human
keratinocytes stimulated with
2.5  107 CFU of heat-inactivated
P. acnes in the presence or absence of
36 mg ml1 SECM (g) or 10 mg ml1
LTA (h). *P < 0.05, **P < 0.01, and
***P < 0.001. P values were analyzed
by one-way ANOVA. Data are the
means  SEM of n ¼ 3 and are
representative of three independent
experiments. ANOVA, analysis of
variance; SECM, S. epidermidis
culture medium; SEM, standard error
of the mean; TNF, tumor necrosis
factor.
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624LTA did markedly inhibit TLR2 protein when TLR2 gene
containing 30UTR was overexpressed in human embryonic
kidney 293 cells, but LTA completely lost its inhibitory effect
on TLR2 protein production when TLR2 gene was lack of
30UTR or miR-143 recognition site in 30UTR of TLR2 gene
was mutated (Figure 5j). Furthermore, overexpression of TLR2
prevented LTA from inhibiting the expression of P. acnes-
induced IL-6 and TNF-a in primary human keratinocytes
(Figure 5k). Taken together, these results demonstrate that LTA
induces miR-143 directly targeting 30UTR of TLR2 and then
specifically inhibits P. acnes-induced TLR2 production, thus
inhibiting P. acnes-induced inflammatory response.
miR143 antagomir abrogates the inhibitory effect of LTA on
P. acnes-induced inflammation in mice
To confirm the physiological relevance of miR-143 in the in-
hibition of P. acnes-induced inflammation in vivo, we treated
mouse ears with miR-143 antagomir before intradermal
administration of living P. acnes and/or LTA. Ears injectedJournal of Investigative Dermatology (2016), Volume 136with living P. acnes and LTA showed less ear swelling and
inflammation compared with those treated only with living
P. acnes, whereas pretreatment with miR-143 antagomir
before injection with living P. acnes and LTA restored this
inflammation in ears (Figure 6a and b). Consistently, LTA
significantly inhibited the production of P. acnes-induced IL-6
and TNF-a or TLR2 protein in mouse ears, but failed to inhibit
P. acnes-induced proinflammatory cytokines or TLR2 protein
in ears pretreated with miR-143 antagomir (Figure 6c and d).
All these data confirm the crucial and selective role of miR-
143 in LTA inhibition of cutaneous inflammation induced by
P. acnes.
DISCUSSION
S. epidermidis, one of the most abundant bacteria on skin, has
been shown to benefit the host by dampening unwanted
inflammation after skin injury or increasing antimicrobial de-
fenses against skin infections (Cogen et al., 2010; Lai et al.,
2009, 2010; Li et al., 2013). Here we reveal a previously




(a) Quantification of IL-6 and TNF-a
mRNA expression in keratinocytes
stimulated by 2.5  107 CFU of
heat-inactivated P. acnes and/or
10 mg ml1 LTA after Dicer was
silenced. Quantification of pre-miR-
146a and pre-miR-143 mRNA
expression in keratinocytes (b), mouse
ears (c), or macrophage RAW264.7 (d)
stimulated by 10 mg ml1 LTA. The
expression of IL-6 and TNF-a mRNA
in keratinocytes stimulated with
2.5  107 CFU of heat-inactivated
P. acnes after transfection with pre-
miR-146a (e) or pre-miR-143 (f)
overexpression vector. Quantification
of IL-6 and TNF-a mRNA expression
in keratinocytes treated with 2.5  107
CFU of heat-inactivated P. acnes
and/or 10 mg ml1 LTA after
transfection with miR-146a (g) or
miR-143 (h) inhibitors. *P <
0.05,**P < 0.01, and ***P < 0.001.
P values were determined by two-way
ANOVA (a, eeh) or one-way ANOVA
(bed). Data are representative of three
independent experiments and are
means  SEM of n ¼ 3. ANOVA,
analysis of variance; LTA, lipoteichoic
acid; SEM, standard error of the mean;
TNF, tumor necrosis factor.
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LTA Inhibits P. acnes-Induced Inflammationunreported function of S. epidermidis in regulating cutaneous
inflammation induced by P. acnes. We show that
S. epidermidis and its byproduct LTA can inhibit P. acnes-
induced inflammatory response in skin. The inhibitory effect
is mediated by staphylococcal LTA-induced miR-143 on
keratinocytes. The mechanism for LTA-miR-143-mediated
suppression of TLR2 signaling is accomplished by miR-143
targeting 30UTR of TLR2 and then decreasing the produc-
tion of TLR2 protein, an event we show has a major role in
inhibiting P. acnes-induced cutaneous inflammation. Thus,
this study suggests the normal skin resident bacterium
S. epidermidis could function in a beneficial way to limit the
extent of inflammation caused by P. acnes via the induction
of miR-143. These findings also offer potential targets for
treatment with acne vulgaris.
The inflammatory characteristics of acne vulgaris have
been associated with the host immune response to P. acnes, a
commensal human skin bacterium found in the piloseba-
ceous follicles. P. acnes induces the production of inflam-
matory cytokines in freshly isolated peripheral blood
mononuclear cells from patients with acne and normalcontrols (Vowels et al., 1995) as well as in keratinocytes (Lyte
et al., 2009). Here we also confirm that P. acnes-activated
TLR2 to induce the expression of proinflammatory cytokines
in primary keratinocytes, macrophages, and mouse skin.
The induction of proinflammatory cytokines by P. acnes was
selectively inhibited by SECM and staphylococcal LTA in
keratinocytes but not in macrophages. These distinct effects
of SECM and staphylococcal LTA on macrophages and ker-
atinocytes can be explained by that macrophages recognize
LTA as foreign because macrophages normally exist in a
sterile environment and are not normally exposed to the
surface microbiome, whereas keratinocytes frequently
exposed to LTA and permit the survival of S. epidermidis
on the skin (Lai et al., 2009). Moreover, it should be noted
that we used LTA from S. aureus instead of LTA from
S. epidermidis to inhibit P. acnes-induced inflammatory
response in this study. This is because only LTA from S. aureus
is commercially available and shares the similar structure of
LTA from S. epidermidis because of the synthesis and modi-
fication of these two LTAs controlled by the same gene ItaS
and dlt operon (Weidenmaier et al., 2004). Therefore, wewww.jidonline.org 625
Figure 4. The induction of miR-143 by LTA is dependent on TLR2. The
expression of TLR2 mRNA in primary human keratinocytes (a) or murine
keratinocytes (b) or in mouse ears (c) stimulated by 10 mg ml1 LTA. The
production of TLR2 protein in primary human keratinocytes (d) or murine
keratinocytes (e) or in mouse ears (f) stimulated by 10 mg ml1 LTA. (g) The
expression of LTA-induced pre-miR-143 in primary human keratinocytes.
(h) The expression of pre-miR-143 induced by 10 mg of LTA in wild-type and
Tlr2-deficient murine keratinocytes. (i) The expression of pre-miR-143
induced by 10 mg of LTA in wild-type mouse ears. (j) The expression of
LTA-induced pre-miR-143 in wild-type and Tlr2-deficient mouse ears.
*P < 0.05 and ***P < 0.001. P values were determined by one-way ANOVA.
Data are the means  SEM of n ¼ 3 or n ¼ 6 (g) and representative of three
independent experiments. ANOVA, analysis of variance; LTA, lipoteichoic
acid; SEM, standard error of the mean; TLR, toll-like receptor.
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626observed that S. aureus LTA exerted the same biological
activity as SECM on the inhibition of P. acnes-induced
inflammatory cytokines in keratinocytes, which is consistent
with our previous observation that LTAs from both S. aureus
and S. epidermidis can activate TLR2 to induce TRAF1 for the
inhibition of TLR3-mediated inflammatory response in kera-
tinocytes (Lai et al., 2009). Although we used LTA from
S. aureus instead of LTA from S. epidermidis, staphylococcalJournal of Investigative Dermatology (2016), Volume 136LTA as well as SECM not only inhibited the production of
proinflammatory cytokines by cultured keratinocytes expo-
sure to P. acnes but also inhibited P. acnes-induced inflam-
mation in vivo. These findings suggest that the activation of
TLR2 by P. acnes in keratinocytes might initiate inflammatory
response during acne development, and staphylococcal LTA
inhibits the production of proinflammatory cytokines by
keratinocytes, thus controlling acne inflammation.
miRNAs has been shown to regulate diverse immune
responses and immunologic disorders (Bartel, 2004; Greene
and Gaughan, 2013; Xie et al., 2013). Specifically, several
microRNAs such as miR-146 and miR-155 have been
reported to control TLR signaling through targeting 30UTRs
of TRAF6, IL-1 receptor-associated kinase 1, or TAB2 genes,
thus reducing the production of inflammatory cytokines
(Ceppi et al., 2009; Taganov et al., 2006). Here we demon-
strate a different way of miRNAs to control TLR signaling via
directly targeting 30 UTR of TLR2 by miR-143, thus reducing
the production of TLR2 protein and then inhibiting TLR2-
mediated inflammatory response in keratinocytes. However,
we observed that staphylococcal LTA induced miR-143
dependent on the activation of TLR2, and then miR-143, in
turn, targeted 30 UTR of TLR2 mRNA to decrease TLR2 pro-
tein, suggesting a feedback regulation of TLR2 itself. In line
with this, we have also observed that the induction of TLR2
by LTA reached its maximum always before the maximum
expression of miR-143 induced by LTA either in keratinocytes
or in mouse ears (Figure 4aei). Moreover, we observed that
LTA significantly inhibited P. acnes-induced the expression of
IL-6 and TNF-a only when LTA was added 2 hours before or
together with P. acnes stimulation, but was not able to inhibit
this event when it was added 2 hours after P. acnes stimu-
lation (Figure 6aec, Supplementary Figure S2a and b online).
Consistent with this, LTA markedly inhibited P. acnes-
induced TLR2 protein when it was administrated 2 hours
before or together with P. acnes stimulation in primary
human keratinocytes and in mouse ears (Figures 4f and 6d;
Supplementary Figure S2c and d). All these suggest that a
sensitive balance between LTA induction of miR-143 and the
inhibition of TLR2-mediated inflammatory response by LTA
should be tightly controlled. Otherwise, staphylococcal LTA
will lose its capacity to inhibit P. acnes-induced inflamma-
tion in skin.
Our previous study has shown that S. epidermidis and its
byproduct LTA suppress TLR3-dependent inflammation by
the induction of a negative regulator TRAF1 after skin injury
(Lai et al., 2009). Here, we have discovered that staphylo-
coccal LTA induces miR-143 to suppress TLR2-mediated
inflammation. These findings suggest that commensal bac-
terium S. epidermidis mediates different regulatory factors in
response to different TLR signaling in keratinocytes. Although
Huang’s group has shown that S. epidermidis employs glyc-
erol fermentation to rein in the overgrowth of P. acnes (Wang
et al., 2014), in our setting we did not find that SECM or LTA
could inhibit the overgrowth of P. acnes (Figure 1eeh). This
finding accompanied by the observation that P. acnes and
S. epidermidis co-colonize in acne vulgaris suggests that the
inhibition of P. acnes inflammation by S. epidermidis is
probably not due to inhibition of the growth of P. acnes, but
mainly dependent on miR-143.
Figure 5. LTA induces miR-143 targeting 30UTR of TLR2 to inhibit P. acnes-induce inflammation in skin. (a) The expression of IL-6 and TNF-a mRNA in
primary human keratinocytes treated with TLR2 inhibitor OxPAPC (30 mg ml1) before stimulation by 2.5  107 CFU of heat-inactivated P. acnes. (b) The
expression of IL-6 and TNF-a mRNA induced by 2.5  107 CFU of heat-inactivated P. acnes in wild-type and Tlr2-deficient murine keratinocytes.
(c) Photographs and the thicknesses of ears of wild-type and Tlr2-deficient mice 24 hours after intradermal injection with PBS or 2.5  107 CFU of living
P. acnes. (d) Quantification of IL-6 and TNF-a mRNA expression in ears of wild-type and Tlr2-deficient mice 24 hours after intradermal injection with PBS
or 2.5  107 CFU of living P. acnes. TLR2 mRNA (e) and protein (f) expression in keratinocytes exposed to 2.5  107 CFU of P. acnes after miR143 was
overexpressed. (g) Normalized luciferase activity in Hela cells transfected with 30UTR of TLR2 with or without point mutations in miR-143 recognition site.
(h) Normalized luciferase activity in Hela cells transfected with 30UTR of TLR2 treated with 10 mg ml1 LTA or PBS. (i) The inhibitory effect of 10 mg ml1 LTA on
the luciferase activity driven by 30UTR of TLR2 or 30UTR of TLR2 with point mutations in miR-143 recognition site. (j) The inhibitory effect of 10 mg ml1 LTA
on TLR protein production in HEK293 cells transfected with the vector containing only TLR2 alone, or TLR2 with 30UTR, or TLR2 with point mutations in
miR-143 recognition site of 30UTR. (k) Quantification of IL-6 and TNF-a mRNA expression stimulated with 2.5  107 CFU of heat-inactivated P. acnes in the
presence or absence of 10 mg ml1 LTA after TLR2 was overexpressed in primary human keratinocytes. **P < 0.01 and ***P < 0.001. n.s. no significance.
P values were determined by one-way ANOVA (a) or two-way ANOVA (bee, gei, k). Data are representative of three independent experiments with n ¼ 3
(a, b, eek) or n ¼ 6 (c, d) per group and are means  SEM. ANOVA, analysis of variance; HEK, human embryonic kidney; LTA, lipoteichoic acid; OxPAPC,
oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine; SEM, standard error of the mean; TLR, toll-like receptor; TNF, tumor necrosis factor.
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Figure 6. miR-143 antagomir
abrogates the inhibitory effect of LTA
on P. acnes-induced inflammation in
mice. (a, b) Photographs and the
thicknesses of ears of wild-type (WT)
mice 24 hours after intradermal
injection with 10 mg LTA and/or 2.5 
107 CFU of living P. acnes after mice
were treated with miR-143 16 mg
antagomir. (c) Quantification of IL-6
and TNF-a protein production in ears
of WT 24 hours after intradermal
injection with 10 mg LTA and/or 2.5 
107 CFU of living P. acnes in WT mice
that were treated with 16 mg miR-143
antagomir. (d) TLR2 protein
production in ears of WT 24 hours
after intradermal injection with 10 mg
LTA and/or 2.5  107 CFU of living
P. acnes in WT mice that were treated
with 16 mg miR-143 antagomir. **P <
0.01 and ***P < 0.001. n.s. no
significance. P values were
determined by two-way ANOVA.
Data are the means  SEM of n ¼ 6
and representative of two independent
experiments. ANOVA, analysis of
variance; LTA, lipoteichoic acid; SEM,
standard error of the mean; TLR, toll-
like receptor.
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628In conclusion, these findings support our discovery that
S. epidermidis plays an important role in regulating cuta-
neous inflammation in skin. Induction of miR-143 by staph-
ylococcal LTA is critical for the inhibition of P. acnes-induced
inflammation in keratinocytes and might be a previously
unknown key element in the control of inflammation in acne
vulgaris. Our findings implicate the potential of TLR2 and
miR-143 as therapeutic targets in acne vulgaris. These
observations also suggest that local modulation of the
inflammatory response by products of bacterial commensals
at the site of acne vulgaris might be a beneficial therapeutic
strategy for management of P. acnes-induced cutaneous
inflammatory responses.
MATERIALS AND METHODS
Mice and bacterial strains
Tlr2/ breeding pair was purchased from the Jackson Laboratory
(Sacramento, CA). C57BL/6 mice and age-matched Tlr2/ mice
were housed in the animal facility at East China Normal University.Journal of Investigative Dermatology (2016), Volume 136All animal experiments were performed according to the protocol
approved by the East China Normal University Animal Care and Use
Committee and in direct accordance with Ministry of Science and
Technology of the People’s Republic of China on Animal Care
guidelines.
P. acnes DMSZ 1897 from Dr. Teruaki Nakatsuji in University of
California-San Diego was grown in the reinforced clostridial
medium (Oxoid, Basingstoke, UK) to mid-log phase at 37 C under
the anaerobic condition using the MGC Anaeropack systems
(Mitsubishi Gas Chemical, Tokyo, Japan). To stimulate cells P. acnes
was heat-inactivated at 65 C for 30 minutes and serially diluted to
different concentrations. For intradermal injection in mice ears,
living P. acnes was directly diluted to the indicated concentrations.
Cell culture and stimulation
Human embryonic kidney 293, Hela cells, and human epidermal
keratinocytes (Cascade Biologics, Portland, OR) were cultured as
previously reported (Lai et al., 2012). A total of 2  105 cells were
seeded in each well of 24-well plates or 8  105 cells were seeded in
X Xia et al.
LTA Inhibits P. acnes-Induced Inflammationeach well of 6-well plates. Cells were grown to 80% confluence
before the indicated doses of heat-inactivated P. acnes, Staphylo-
coccal LTA (Sigma-Aldrich, Shanghai, China), or different inhibitors
were used to stimulate cells. Finally, cells were collected for RNA
isolation or western blotting at indicated times.
Gene silencing
Oligonucleotides encoding Dicer small interfering RNAs (shown
in Supplementary Table S1 online) were designed as previously
reported (Lai et al., 2012). Small interfering RNAs were directly
transfected into keratinocytes by using lipofectamine 2000 trans-
fection reagent (Invitrogen, Carlsbad, CA). The silencing efficiency of
small interfering RNAs in keratinocytes was tested by quantitative
real-time reverse-transcriptase-PCR.
Real-time quantitative reverse-transcriptase-PCR
Aliquots of a reverse transcription mixture were analyzed by quan-
titative real-time reverse-transcriptase-PCR by using specific primer
sets (shown in Supplementary Table S1). SYBR Green real-time PCR
master mix (Roche, Pleasanton, CA) was used according to the
manufacture’s protocol. All reactions were independently repeated
at least three times to ensure the reproducibility of the results.
Enzyme-linked immunosorbent assay
The supernatants of skin homogenate were collected and assayed for
cytokines. Cytokine production was measured by ELISA for mTNF-a
(BD Biosciences, San Jose, CA) and mIL-6 (R&D systems, Minne-
apolis, MN) according to the protocol of the manufacturer.
Western blot analysis
Cells were lysed in 2  SDS loading buffer or whole ears of mice
were taken and homogenized with phosphate buffered saline (PBS)
containing inhibitors of protease and phosphatase (Roche, Pleas-
anton, CA). Fifty micrograms of total protein was used for immu-
noblot. Samples were separated with SDS-PAGE and then transferred
to nitrocellulose membranes followed by probing with TLR2 anti-
body (ABclonal Biotechnology, Cambridge, MA).
Luciferase reporter assay
A total of 5  104 Hela cells were seeded into 24-well plates. The
cells were cultured for 12 hours and then were cotransfected with
10 ng luciferase reporter vectors and 300 ng TLR2 overexpression
vector containing 30 UTR of TLR2 with or without the mutation in
miR-143 recognition site. Different doses of pre-miR-143 were
simultaneously overexpressed or 10 mg ml1 LTA was used to
stimulate in cells. After 24 hours, cells were lysed with passive lysis
buffer (Promega, Beijing, China) and dual-luciferase activity was
assayed using a luminometer (Bio-Gene, Hong Kong, China). Each
assay was performed in triplicate and independently repeated three
times.
P. acnes-induced inflammation in vivo
Living P. acnes (2.5  107 CFU per ear) was intradermally injected
into the ears of wild-type or Tlr2/mice. Staphylococcal LTA (10 mg
per ear) or miR-143 antagomir (16 mg per ear) was intradermally
injected into mouse ears 2 hours before or together with or 2 hours
after intradermal injection of living P. acnes or PBS. After 24 hours,
mice were euthanized; ear thickness was measured using a micro
caliper (Mitutoyo, Kawasaki, Japan); and then ears were taken either
for RNA isolation or for protein extraction.
Statistical analysis
All data are present as mean  SEM. We used two-tailed t tests to
determine significances between two groups. For multiple groups,we employed one-way or two-way analysis of variance with
Bonferroni posttest using GraphPad prism version 5. For all statistical
tests, we considered P < 0.05 to be statistically significant.
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